{
    "organizations": [],
    "uuid": "afc5849a725c721de90f13c9e31d3042dae8e114",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-tianjin-chase-sun-pharmaceutical-u/brief-tianjin-chase-sun-pharmaceutical-unit-receives-certificate-of-suitability-for-european-pharmacopeia-from-edqm-idUSL4N1PZ1L8",
    "ord_in_thread": 0,
    "title": "BRIEF-Tianjin Chase Sun Pharmaceutical unit receives certificate of suitability for european pharmacopeia from EDQM",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Feb 9 (Reuters) - Tianjin Chase Sun Pharmaceutical Co Ltd\n* Says wholly owned pharmaceutical unit received certificate of suitability for european pharmacopeia (CEP) from European Directorate for the Quality of Medecines(EDQM)\n* Certificate issued to etomidate manufactured by the unit and the valid period is five years\nSource text in Chinese: goo.gl/jgWS2z\nFurther company coverage: (Beijing Headline News)\n ",
    "published": "2018-02-09T10:21:00.000+02:00",
    "crawled": "2018-02-09T16:26:23.027+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "feb",
        "reuters",
        "tianjin",
        "chase",
        "sun",
        "pharmaceutical",
        "co",
        "ltd",
        "say",
        "wholly",
        "owned",
        "pharmaceutical",
        "unit",
        "received",
        "certificate",
        "suitability",
        "european",
        "pharmacopeia",
        "cep",
        "european",
        "directorate",
        "quality",
        "medecines",
        "edqm",
        "certificate",
        "issued",
        "etomidate",
        "manufactured",
        "unit",
        "valid",
        "period",
        "five",
        "year",
        "source",
        "text",
        "chinese",
        "company",
        "coverage",
        "beijing",
        "headline",
        "news"
    ]
}